Gavin Hirst
Chief Tech/Sci/R&D Officer bij TURG POIN
Profiel
Gavin Hirst is Vice President of Chemistry for Mpex Pharmaceuticals, Inc. Prior to joining Mpex in January 2009, he was the Senior Director of Chemistry at SGX Pharmaceuticals and a Medicinal Chemist at Glaxo organization.
Previously, Dr. Hirst held various management and project responsibility positions at Abbott Bioresearch Center.
He has 19 years experience in medicinal chemistry research and the development of pharmaceutical products across multiple therapeutic areas and gene families.
Dr. Hirst received a PhD in Organic Chemistry from the Southampton University in the UK and completed a postdoctoral fellowship at the University of California at Irvine.
Actieve functies van Gavin Hirst
| Bedrijven | Functie | Begin |
|---|---|---|
| TURG POIN | Chief Tech/Sci/R&D Officer | 01-01-2020 |
Eerdere bekende functies van Gavin Hirst
| Bedrijven | Functie | Einde |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | - |
Takeda California, Inc.
 Takeda California, Inc. Pharmaceuticals: MajorHealth Technology Takeda California, Inc. is a pharmaceutical manufacturing company. The private company is based in San Diego, CA. | Corporate Officer/Principal | - |
| Eurofins Discovery Products France SAS | Corporate Officer/Principal | - |
AbbVie Bioresearch Center, Inc.
 AbbVie Bioresearch Center, Inc. BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Bioresearch Center, Inc. is a private company that provides drug discovery, development sciences, and biologics research services. The company is based in Worcester, MA. | Corporate Officer/Principal | - |
Opleiding van Gavin Hirst
| The University of Southampton | Doctorate Degree |
| University of California | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Health Technology |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Commercial Services |
| Glaxo, Inc. | |
AbbVie Bioresearch Center, Inc.
AbbVie Bioresearch Center, Inc. BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Bioresearch Center, Inc. is a private company that provides drug discovery, development sciences, and biologics research services. The company is based in Worcester, MA. | Health Technology |
Takeda California, Inc.
Takeda California, Inc. Pharmaceuticals: MajorHealth Technology Takeda California, Inc. is a pharmaceutical manufacturing company. The private company is based in San Diego, CA. | Health Technology |
| Eurofins Discovery Products France SAS |
